Mazdutide combines GLP-1 and glucagon receptor agonism to target hepatic lipid clearance, basal energy expenditure, and systemic weight reduction in metabo
Read more Mazdutide and Hepatic Metabolism: Glucagon Co-Agonism, Liver Fat, and Energy Expenditure
Thymosin Alpha-1 has been evaluated across dozens of clinical trials for hepatitis, sepsis, and oncology. This review examines its human evidence, safety,
Read more Thymosin Alpha-1 in Clinical Trials: A Review of Human Evidence
Survodutide is an investigational dual GLP-1/glucagon receptor agonist under active evaluation for metabolic dysfunction-associated steatohepatitis (MASH).
Read more Survodutide in MASH Research: Clinical Evidence and Hepatic Mechanisms
A scientific review of elamipretide (SS-31) clinical trials, examining human evidence in Barth syndrome, primary mitochondrial myopathies, cardiovascular d
Read more SS-31 (Elamipretide) Clinical Trials: Human Evidence and Regulatory Review
A rigorous scientific breakdown separating myths from published clinical evidence on how semaglutide influences body composition, skeletal muscle preservat
Read more Semaglutide: Myths vs. Evidence on Body Composition and Metabolic Research
Semax and Selank are synthetic heptapeptides developed from distinct endogenous parent molecules. While Semax targets neurotrophin expression and neuroprot
Read more Semax vs. Selank: Comparative Mechanisms, Neurochemistry, and Research Evidence
A comparative scientific review of tirzepatide and semaglutide, examining receptor pharmacology, dual GIP/GLP-1 agonism versus selective GLP-1 activation,
Read more Tirzepatide vs. Semaglutide: Comparative Pharmacology and Research Evidence
Adamax is an experimental adamantane-modified analog of the neuropeptide Semax. While theoretical models suggest improved enzymatic stability and membrane
Read more Adamax Research: Safety Gaps, Regulatory Status, and Unanswered Questions
Retatrutide in liver disease research shows remarkable reductions in hepatic fat. Clinical trials reveal triple GIP/GLP-1/glucagon receptor agonism resolve
Read more Retatrutide in Liver Disease Research: Evidence for Hepatic Fat Reduction
Glutathione serves as an essential intracellular cofactor for glutathione peroxidase 4 (GPX4), preventing ferroptosis—an iron-dependent form of non-apoptot
Read more Glutathione and Ferroptosis: Mechanisms of Redox Defense and Cell Death